Celerion, Inc.

Lincoln, Nebraska 68502

2 studies enrolling now · 31 studies all time

What they study most

Dermatitis, Atopic, Eosinophilic Esophagitis, Healthy, Healthy Participants, Healthy Subjects, Healthy Volunteer, Healthy Volunteers, Heparin-induced Thrombocytopenia, Hepatitis B, Impulse Control Disorders, Infectious Disease, Liver Diseases

Studies at this site

• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants — Recruiting now
• A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participants — Completed
• A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults — Starting soon
• A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men — Completed
• Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants — Stopped early
• Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, & Food Effect of Oral INCB000631 to Healthy Adult Participants — Completed
• Study of BLU-808 in Healthy Adult Participants — Completed
• A Relative Bioavailability Study and Food Effect Study of AB521 in Healthy Adult Volunteers — Completed
• A Study to Evaluate Skin and Plasma Pharmacokinetic of Multiple Doses of Povorcitinib After Oral Administration in Healthy Participants — Completed
• A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants. — Completed
• A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis — Completed
• BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability — Completed
• Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis — Completed
• A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects — Completed
• A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects — Completed
• Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male Subjects — Completed
• First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People — Completed
• A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling — Completed
• Phase I Study of VLX-1005 in Healthy Subjects — Completed
• A Phase 1 Study of Subcutaneous CDX-0159 in Healthy Subjects — Completed
• A Study in Healthy Volunteers — Completed
• Single-dose AME Study With [14C]AR882 in Healthy Male Subjects — Completed
• Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal — Completed
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MRG-110 Following Intradermal Injection in Healthy Volunteers — Completed
• Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers — Completed
• A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System — Completed
• Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects — Completed
• Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine — Completed
• Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers — Completed
• CSD170401: Study to Assess Elements of Abuse Liability for Three Electronic Tobacco Vapor Products During an 11-Day In-Clinic Confinement — Completed
• Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM — Completed